𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Activating anti-idiotypic human anti-mouse antibodies for immunotherapy of ovarian carcinoma

✍ Scribed by R. P. Baum; A. Niesen; A. Hertel; A. Nancy; H. Hess; B. Donnerstag; T. R. Sykes; C. J. Sykes; M. R. Suresh; A. A. Noujaim; G. Hör

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
380 KB
Volume
73
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-immunoglobulin antibodies IV. Cross
Anti-immunoglobulin antibodies IV. Cross-reaction of anti-idiotypic antibodies specific for rabbit and murine anti-a1 allotype antibodies with Fc fragment of human immunoglobulins
✍ Constantin A. Bona; Burt Goldberg; Dennis Metzger; Jacques Urbain; Henry G. Kunk 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 541 KB

## Anti-immunoglobulin antibodies IV. Cross-reaction of anti-idiotypic antibodies specific for rabbit and murine anti-al allotype antibodies with Fc fragment of human immunoglobulins\* Anti-idiotype (Id) antibodies against anti-al rabbit allotype antibodies were produced in rabbits and mice by immu

Inhibition of bispecific monoclonal anti
Inhibition of bispecific monoclonal antibody (bsAb)-targeted cytolysis by human anti-mouse antibodies in ovarian carcinoma patients treated with bsAb-targeted activated T-lymphocytes
✍ Cor H. J. Lamers; Jan W. Gratama; Sven O. Warnaar; Gerrit Stoter; Reinder L. H. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 743 KB

T lymphocytes of 8 patients with ovarian cancer were targeted to the tumor cells using F(ab')2 fragments of a bispecific monoclonal antibody (bsAb), specific for CD3 (a component of the T lymphocyte receptor for antigen) and for the folate receptor MOv I 8 (overexpressed by ovarian carcinoma cells)

Level of anti-mouse-antibody response in
Level of anti-mouse-antibody response induced by bi-specific monoclonal antibody OC/TR in ovarian-carcinoma patients is associated with longer survival
✍ Silvia Miotti; Donatella R.M. Negri; Olga Valota; Marcella Calabrese; Reinder L. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 88 KB

More than 60% of cancer patients injected with intact murine monoclonal antibody (MAb) develop a humoral response against the antigen even after a single dose. Analysis of a series of 35 ovarian-cancer patients entered in phase-I and -II clinical studies of T-cells retargeted with the bi-specific F(

Induction of cellular immune responses b
Induction of cellular immune responses by a murine monoclonal anti-idiotypic antibody recognizing the 791tgp72 antigen expressed on colorectal, gastric and ovarian human tumours
✍ Lindy G. Durrant; Mark Doran; Eric B. Austin; R. Adrian Robins 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 525 KB

There is accumulating evidence that cellular rather than antibody responses are more effective for tumour rejection. It is therefore important to screen anti-idiotypic (anti-id) antibodies for their ability to stimulate anti-tumour T-cell responses. The human anti-id monoclonal antibody (MAb) I05AD7